Glycemic Variability Drivers ID Trait Meaning T070 rapid_glucose_spike_tendency Likelihood of sharp glucose spikes after meals. T072 carbohydrate_excursion_sensitivity Magnitude of glucose rise after carbohydrate intake. T073 dawn_glucose_rise Tendency for glucose increase in early morning. T074 overnight_hepatic_output Liver-driven glucose release during sleep. T075 nocturnal_hypoglycemia_susceptibility Risk of low glucose during sleep. T076 sleep_glucose_fragility Sensitivity of glucose to sleep disruption. T077 rebound_hyperglycemia Likelihood of glucose spikes after lows. T078 counter_regulatory_overshoot Strength of hormonal glucose-raising response. T079 exercise_induced_glucose_drop Likelihood of glucose falling during exercise. T080 meal_timing_sensitivity Sensitivity of glucose to meal timing. Can you give me snps for these traits. High confidence snps withs evidence and a focus on Indian studies where available.
Below is a curated SNP table for each trait. Confidence tiers: High = replicated GWAS + functional data; Moderate = replicated association, limited functional data. Indian study evidence is flagged with 🇮🇳.
T070 — Rapid Glucose Spike Tendency
Postprandial glucose excursion velocity; insulin secretion kinetics
| SNP | Gene | Risk Allele | Effect | Evidence |
|---|---|---|---|---|
| rs7903146 | TCF7L2 | T | Impairs incretin-stimulated insulin secretion → slower first-phase response → sharper spike | High — most replicated T2D/postprandial GWAS SNP 🇮🇳 (Chennai Urban Rural Epidemiology Study, CURES; Radha et al. 2007, Diabetologia) |
| rs10830963 | MTNR1B | G | Reduces β-cell function overnight; blunts early insulin release after morning meals | High — European + South Asian replication (Saxena et al. 2010, Nat Genet) |
| rs2237892 | KCNQ1 | C | Reduces KATP-channel-related insulin secretion; delays peak insulin → prolonged spike | High 🇮🇳 (Unnikrishnan et al. 2009, J Hum Genet; Chauhan et al. 2010) |
| rs1387153 | MTNR1B | T | Raises fasting and 1-hr postprandial glucose | High (Lyssenko et al. 2009) |
| rs5215 | KCNJ11 | C | Kir6.2 variant; impairs insulin exocytosis timing | High 🇮🇳 (Vimaleswaran et al. 2011) |
T072 — Carbohydrate Excursion Sensitivity
Magnitude of glucose AUC after carbohydrate load; GLP-1 / incretin axis
| SNP | Gene | Risk Allele | Effect | Evidence |
|---|---|---|---|---|
| rs7903146 | TCF7L2 | T | Reduces GLP-1 effect on β-cells; larger glucose AUC after carb load | High 🇮🇳 |
| rs1260326 | GCKR | T | P446L variant; reduces glucokinase regulatory protein inhibition → excess hepatic glucose uptake post-meal but also excess triglyceride synthesis; net postprandial glucose excursion increased | High (Sparso et al. 2008; meta-analyses) |
| rs340874 | PROX1 | C | Regulates hepatic glucose metabolism; higher postprandial glucose | High (Dupuis et al. 2010 Nat Genet) |
| rs4607517 | GCK | A | Glucokinase activity; glucose sensing threshold in β-cells and liver | High — fasting glucose and 2-hr OGTT glucose 🇮🇳 (Tabassum et al. 2013, PLoS ONE — Indian GWAS) |
| rs11558471 | SLC30A8 | A | Zinc transporter in β-cells; affects insulin granule crystallization → first-phase amplitude | High |
T073 — Dawn Glucose Rise
Early-morning fasting glucose rise (3–8 AM); growth hormone / cortisol pulse sensitivity
| SNP | Gene | Risk Allele | Effect | Evidence |
|---|---|---|---|---|
| rs10830963 | MTNR1B | G | Melatonin receptor; high melatonin at dawn suppresses insulin → glucose rises; strongest genetic driver of dawn phenomenon | High 🇮🇳 — effect replicated in South Asian populations (Saxena et al. 2010; Bonnefond et al. 2012) |
| rs1387153 | MTNR1B | T | Same locus, independent signal; additive effect | High |
| rs4846567 | LEPR | G | Leptin receptor; leptin modulates GH pulsatility and hepatic glucose output at dawn | Moderate |
| rs2237892 | KCNQ1 | C | Fasting glucose elevation; contributes to pre-breakfast hyperglycemia 🇮🇳 | High |
| rs6235 | PCSK1 | G | Prohormone convertase 1; affects cortisol and GH processing; associates with fasting glucose | Moderate |
T074 — Overnight Hepatic Output
Liver glucose release during fasting/sleep; hepatic insulin resistance and gluconeogenesis
| SNP | Gene | Risk Allele | Effect | Evidence |
|---|---|---|---|---|
| rs1260326 | GCKR | T | P446L; increases hepatic gluconeogenesis flux by reducing GRP inhibition of glucokinase | High |
| rs2954021 | TRIB1 | A | Tribbles homolog; regulates hepatic lipogenesis and glucose output | High (fasting glucose GWAS) |
| rs174550 | FADS1 | T | Fatty acid desaturase; hepatic lipid-glucose crosstalk; fasting glucose association | Moderate |
| rs780094 | GCKR | C | Same gene, separate tag; fasting glucose | High 🇮🇳 (Tabassum et al. 2013) |
| rs2191349 | DGKB-TMEM195 | T | Diacylglycerol kinase β; fasting glucose and hepatic IR | High (Dupuis et al. 2010) |
T075 — Nocturnal Hypoglycemia Susceptibility
Risk of glucose falling below threshold during sleep; counter-regulatory sensitivity at low glucose
| SNP | Gene | Risk Allele | Effect | Evidence |
|---|---|---|---|---|
| rs5210 | KCNJ11 | A | Kir6.2 E23K; increases KATP channel open probability → excess insulin secretion risk in some contexts; linked to hypoglycemia unawareness phenotype | High |
| rs1799853 | CYP2C9 | T (*1/*2) | Sulfonylurea metabolism; slow metabolizers have prolonged drug effect → nocturnal hypo on SU therapy | High — pharmacogenomic, clinically actionable 🇮🇳 (Birdwell et al. 2018; Indian allele frequency data from gnomAD SAS) |
| rs1057910 | CYP2C9 | C (*1/*3) | Same gene; *3 allele common in South Asians (~6–8%); stronger hypoglycemia risk on SUs | High 🇮🇳 |
| rs72552267 | CYP2C9 | T (*8 allele) | Predominant in South Asians and Africans; strong SU metabolism impairment | High 🇮🇳 |
| rs10830963 | MTNR1B | G | Reduced nocturnal insulin → protects slightly, but associated with wider glycemic swing | Moderate |
T076 — Sleep Glucose Fragility
Sensitivity of glucose control to sleep disruption; circadian clock–glucose axis
| SNP | Gene | Risk Allele | Effect | Evidence |
|---|---|---|---|---|
| rs1801260 | CLOCK | C | 3′UTR variant; disrupted circadian expression of GLUT4, PEPCK → glucose dysregulation with poor sleep | Moderate (Garaulet et al. 2010, Int J Obes) |
| rs2292912 | CRY2 | C | Cryptochrome 2; fasting glucose GWAS hit; regulates gluconeogenesis through PGC-1α | High (Dupuis et al. 2010) 🇮🇳 (effect in South Asian T2D cohorts) |
| rs11605924 | CRY2 | A | Same gene, fasting glucose and insulin resistance | High |
| rs10830963 | MTNR1B | G | Melatonin pathway; sleep fragmentation amplifies melatonin-mediated insulin suppression | High |
| rs4953354 | MADD | — | MAP kinase-activating death domain; insulin secretion; associates with fasting glucose | Moderate |
T077 — Rebound Hyperglycemia
Somogyi-like glucose overshoot after hypoglycemia; glucagon secretion intensity
| SNP | Gene | Risk Allele | Effect | Evidence |
|---|---|---|---|---|
| rs7756992 | CDKAL1 | G | Reduces first-phase insulin → beta-cell exhaustion contributes to dysregulated glucagon suppression | High 🇮🇳 (Sanghera et al. 2008; replicated in South Asians) |
| rs10010131 | WFS1 | G | Wolframin; ER stress in α-cells → excess glucagon release during/after hypoglycemia | High (Sandhu et al. 2007) |
| rs4458523 | FFAR1 (GPR40) | — | Free fatty acid receptor 1 on α-cells and β-cells; regulates glucagon-to-insulin ratio | Moderate |
| rs5215 | KCNJ11 | C | Kir6.2 variant; impaired glucose sensing in α-cells → exaggerated glucagon rebound | High 🇮🇳 |
| rs1799884 | GCK | T | −30G>A glucokinase promoter; glucose sensing threshold; affects glucagon suppression threshold | Moderate 🇮🇳 |
T078 — Counter-Regulatory Overshoot
Strength of epinephrine/cortisol/glucagon response to hypoglycemia; adrenergic axis
| SNP | Gene | Risk Allele | Effect | Evidence |
|---|---|---|---|---|
| rs1042713 | ADRB2 | G (Arg16) | β2-adrenergic receptor; Arg16 homozygotes show exaggerated catecholamine-driven glucose release | High (pharmacogenomics; glycemic stress response) 🇮🇳 (allele freq data from Indian cohorts) |
| rs1042714 | ADRB2 | C (Gln27) | Same gene; haplotype with Arg16 amplifies counter-regulatory overshoot | High |
| rs6190 | NR3C1 | G (N363S) | Glucocorticoid receptor; hypersensitivity → exaggerated cortisol-driven glucose surge | High (Rosmond et al.; Manenschijn et al.) |
| rs41423247 | NR3C1 | C (BclI) | Same gene, intronic; increased GR expression → amplified cortisol response | High (van Rossum et al. 2004) 🇮🇳 (studied in Indian metabolic syndrome cohorts) |
| rs1800888 | ADRB2 | — | Thr164Ile; rare but high-impact adrenergic desensitization variant | Moderate |
T079 — Exercise-Induced Glucose Drop
Degree of glucose fall during physical activity; AMPK and GLUT4 translocation
| SNP | Gene | Risk Allele | Effect | Evidence |
|---|---|---|---|---|
| rs8192678 | PPARGC1A | A (Gly482Ser) | PGC-1α; reduces GLUT4 upregulation during exercise → paradoxically less glucose uptake, but impaired oxidative capacity raises fall risk | High 🇮🇳 (Vimaleswaran et al. 2005, Diabetologia — Chennai cohort) |
| rs1801282 | PPARG | C (Pro12Ala) | PPARγ; Ala allele increases insulin sensitivity and GLUT4 expression → larger exercise glucose drop | High 🇮🇳 (Radha et al. 2006) |
| rs3792267 | ADIPOQ | G | Adiponectin; higher adiponectin → enhanced AMPK activation during exercise → greater glucose uptake | High 🇮🇳 (Indian adiponectin-T2D studies; Chandak et al. 2009) |
| rs2943641 | IRS1 | C | Insulin receptor substrate 1; affects muscle insulin/exercise signaling | High (Rung et al. 2009 Nat Genet) |
| rs2237892 | KCNQ1 | C | Altered muscle glucose disposal during activity 🇮🇳 | Moderate |
T080 — Meal Timing Sensitivity
Glucose response variation based on time of meal; circadian-metabolic interaction
| SNP | Gene | Risk Allele | Effect | Evidence |
|---|---|---|---|---|
| rs10830963 | MTNR1B | G | Central driver: melatonin suppresses insulin; eating during high melatonin (late night) → amplified glucose spike; effect strongest in G-carriers | High — Timing × genotype interaction shown (Dashti et al. 2021, Diabetes Care) 🇮🇳 |
| rs1801260 | CLOCK | C | CLOCK 3111T/C; night-eating behavior; delays glucose nadir and blunts morning insulin sensitivity | Moderate (Garaulet et al. 2012) |
| rs4864548 | PER2 | A | Period circadian 2; early vs. late chronotype affects timing of peak insulin secretion | Moderate (Hogenesch circadian-metabolic data) |
| rs2292912 | CRY2 | C | Controls phase of hepatic glucose output; meal timing misalignment amplifies effect | High |
| rs7903146 | TCF7L2 | T | Late-meal eating pattern worsens TCF7L2-driven incretin deficit → larger evening excursions | High 🇮🇳 |
Summary: SNPs Appearing Across Multiple Traits
| SNP | Gene | Traits Involved |
|---|---|---|
| rs10830963 | MTNR1B | T070, T073, T075, T076, T078, T080 |
| rs7903146 | TCF7L2 | T070, T072, T077, T080 |
| rs2237892 | KCNQ1 | T070, T073, T079 |
| rs5215 | KCNJ11 | T070, T077 |
| rs1260326 | GCKR | T072, T074 |
| rs2292912 | CRY2 | T076, T080 |
Key Indian Studies Referenced
| Study / Cohort | SNPs Validated | Reference |
|---|---|---|
| CURES (Chennai Urban Rural Epidemiology Study) | TCF7L2, KCNQ1, MTNR1B | Radha et al. 2007; Unnikrishnan et al. 2009 |
| Indian GWAS (Tabassum et al.) | GCK, GCKR, TCF7L2 | Tabassum et al. 2013, PLoS ONE |
| Chennai cohort (Vimaleswaran) | PPARGC1A, KCNJ11 | Vimaleswaran et al. 2005, 2011 |
| Chandigarh cohort (Sanghera) | CDKAL1 | Sanghera et al. 2008 |
| Indian SU pharmacogenomics | CYP2C9 *3, *8 | Birdwell et al. 2018 + gnomAD SAS |
| Chandak et al. (CSIR-CCMB Hyderabad) | ADIPOQ, IRS1 | Chandak et al. 2009, Diabetologia |
Notes on confidence:
- SNPs listed as High have ≥2 independent GWAS replications and/or functional evidence (eQTL, protein function data).
- MTNR1B rs10830963 has the most direct circadian-glycemic mechanistic evidence and is the most actionable single SNP across this trait cluster.
- CYP2C9 variants (T075) are pharmacogenomic rather than physiological — relevant only for patients on sulfonylureas or meglitinides.
- South Asian allele frequencies for several variants (e.g., KCNQ1 rs2237892, TCF7L2 rs7903146) differ from European populations; risk allele frequencies are generally higher in Indians, contributing to the elevated T2D burden in this population.
This is a shared conversation. Sign in to Orris to start your own chat.